雷诺嗪治疗肥厚型心肌病患者心绞痛或呼吸困难（RHYME）。 - Suppr

Suppr

超能文献

Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).

作者信息

Gentry James L, Mentz Robert J, Hurdle Melissa, Wang Andrew

出版信息

J Am Coll Cardiol. 2016 Oct 18;68(16):1815-1817. doi: 10.1016/j.jacc.2016.07.758.

DOI:10.1016/j.jacc.2016.07.758

PMID:27737749

Abstract

摘要

相似文献

Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).

J Am Coll Cardiol. 2016 Oct 18;68(16):1815-1817. doi: 10.1016/j.jacc.2016.07.758.

Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.

Circulation. 2016 Jan 5;133(1):39-47. doi: 10.1161/CIRCULATIONAHA.115.019768. Epub 2015 Nov 10.

Ranolazine for Refractory Angina in a Heart Transplant Recipient With Cardiac Allograft Vasculopathy.

Am J Transplant. 2017 May;17(5):1427-1428. doi: 10.1111/ajt.14190. Epub 2017 Feb 1.

Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).

Am J Cardiol. 2020 Aug 15;129:1-4. doi: 10.1016/j.amjcard.2020.05.020. Epub 2020 May 16.

Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial.

J Womens Health (Larchmt). 2019 May;28(5):573-582. doi: 10.1089/jwh.2018.7019. Epub 2019 Mar 19.

New Anti-Anginal Drugs: Ranolazine.

Cardiovasc Hematol Agents Med Chem. 2015;13(1):14-20. doi: 10.2174/1871525713666141219112841.

Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.

Arq Bras Cardiol. 2022 Oct;119(4):619-621. doi: 10.36660/abc.20210711.

Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.

J Am Coll Cardiol. 2017 May 9;69(18):2304-2313. doi: 10.1016/j.jacc.2017.02.056.

Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.

Int J Cardiol. 2023 Jan 1;370:271-278. doi: 10.1016/j.ijcard.2022.10.014. Epub 2022 Oct 10.

Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.

Cardiovasc Revasc Med. 2017 Sep;18(6):431-435. doi: 10.1016/j.carrev.2017.04.012. Epub 2017 Apr 22.

引用本文的文献

Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review.

J Cardiovasc Dev Dis. 2024 Sep 18;11(9):290. doi: 10.3390/jcdd11090290.

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.

Cardiol Ther. 2022 Dec;11(4):491-507. doi: 10.1007/s40119-022-00283-5. Epub 2022 Oct 15.

Preventative therapeutic approaches for hypertrophic cardiomyopathy.

J Physiol. 2021 Jul;599(14):3495-3512. doi: 10.1113/JP279410. Epub 2020 Sep 7.

Ranolazine for Angina in Hypertrophic Cardiomyopathy.

Case Rep Cardiol. 2018 Apr 15;2018:5142572. doi: 10.1155/2018/5142572. eCollection 2018.

Hypertrophic Cardiomyopathy-Past, Present and Future.

J Clin Med. 2017 Dec 12;6(12):118. doi: 10.3390/jcm6120118.

Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Heart Fail Rev. 2017 Nov;22(6):879-888. doi: 10.1007/s10741-017-9648-x.

Therapeutic Strategies Targeting Inherited Cardiomyopathies.

Curr Heart Fail Rep. 2017 Aug;14(4):321-330. doi: 10.1007/s11897-017-0346-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验